Investigation of the effect of modafinil in coronary artery bypass graft surgery

Phase 2

Recruiting

• Conditions: respiratory and cerebral outcomes.; Respiratory failure, unspecified with hypercapnia, Sedative, hypnotic or anxiolytic use, unspecified with sedative, hypnotic or anxiolytic-induced sleep disorder; J96.92, F1

• Registration Number: IRCT20200611047728N1
• Lead Sponsor: Esfahan University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 17 August 2020

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 74

Inclusion Criteria

patients with coronary artery bypass graft surgery
patients with a cardiac ejection fraction of more than 40%

Exclusion Criteria

Patients with hepatic function failure
Patients with renal function failure
Patients with irregular cardiac primary rhythms
Patients with cardiomegaly
patients who have drug addiction
patients who have alcoholism
patients who are using psychiatric drugs

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The time to reach full consciousness. Timepoint: Every hour until you reach full consciousness. Method of measurement: Richmond-Agitation Scale.;Duration of mechanical ventilation in the intensive care unit. Timepoint: Every hour until you reach full consciousness. Method of measurement: In minutes using time meter.;Length of stay in Intensive Care Unit. Timepoint: Every day until discharge from Intensive Care Unit. Method of measurement: By day using Count days.;Carbon dioxide arterial pressure. Timepoint: Every one hour. Method of measurement: Arterial blood samples based on mercury mm.